Related Experiment Video
Updated: Jun 13, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
[Effectiveness and treatment satisfaction in patients with erectile dysfunction in Spain: EDOS study]
A Martín-Morales1, P R Gutiérrez Hernández, F Meijide Rico
1Servicio de Urología, Hospital Carlos Haya, Málaga, España. a.martinmorales@uaims.net
Tadalafil demonstrated superior effectiveness and patient satisfaction for erectile dysfunction (ED) treatment compared to sildenafil and vardenafil in a Spanish cohort. This longer-acting medication enhanced sexual spontaneity and self-confidence.
Area of Science:
- Urology
- Pharmacology
- Men's Health
Background:
- Erectile dysfunction (ED) is a prevalent global health issue impacting patient quality of life.
- Understanding treatment effectiveness and satisfaction is crucial for managing ED.
Purpose of the Study:
- To evaluate the effectiveness and patient satisfaction of ED treatments within the Spanish population.
- To compare tadalafil, sildenafil, and vardenafil in routine clinical settings.
Main Methods:
- An observational, pan-European study involving 1,029 Spanish patients initiating or changing ED treatment.
- Standard questionnaires assessed treatment effectiveness and patient satisfaction at baseline, 3, and 6 months.
Main Results:
- Tadalafil showed higher reported improvements in erections, treatment satisfaction, and sexual self-confidence at 3 months compared to sildenafil and vardenafil.
- Patients on tadalafil experienced a longer time from drug intake to sexual intercourse, suggesting enhanced spontaneity.
- No significant differences in outcomes were observed at 6 months.
Conclusions:
- Tadalafil's longer duration of action may enhance sexual spontaneity and patient satisfaction in ED management.
- The findings support tadalafil as an effective option for improving self-confidence in men with ED.
Related Concept Videos
Dose-Response Relationship: Potency and Efficacy
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...